EP3302477
PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2016EP published:
7.2.2024EP application number:
16799432.6
EPO information:
European Patent Register
Max expiry date:
26.5.2036
Title in English:
PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTERLanguage of the patent:
English
Timeline
Today
27.5.2016EP application
7.2.2024EP Publication
Owner
Name:
Lumosa Therapeutics Co., Ltd.Address:
4F No. 3-2 Park Street Nangang District, Taipei 11503, TW
Name:
Shanghai Lumosa Therapeutics Co., Ltd.Address:
Room 3026, 3rd Floor, Building 1 No. 146, 1st East Fute Road Shanghai Pilot Free Trade Zone, Shanghai 200131, CN
Inventor
Name:
LI, Chan-JungAddress:
Taipei 11503, TW
Name:
CHOU, David, Chih-KuangAddress:
Palo Alto, CA 94306, US
Name:
HUANG, Jin-DingAddress:
Taipei 11503, TW
Name:
TSAI, Shin, Jr.Address:
New Taipei City 235, TW
Name:
KUO, Shu-WenAddress:
Taipei 11503, TW
Name:
TIEN, Yu-EnAddress:
Taipei 11503, TW
Priority
Number:
201514723996Date:
28.5.2015Country:
US
Number:
201562255805 PDate:
16.11.2015Country:
US
Classification
Categories:
A61K 31/485, A61K 9/08, A61K 47/14, A61K 47/44, A61P 25/04